Pacific Northwest Gov. Christine Gregoire will lead a trade mission to Europe in June to coincide with the Paris Air Show, accompanied by...

Share story



Gov. Christine Gregoire will lead a trade mission to Europe in June to coincide with the Paris Air Show, accompanied by representatives of regional economic-development councils in the state.


Gregoire said she will focus on persuading European aerospace suppliers that have contracts on Boeing’s 787 to locate work in Washington. The low value of the dollar against European currencies makes this a good time for investment in the United States, she said.


One specific goal Gregoire mentioned is ambitious, to say the least. She will meet with top executives from Rolls Royce of the United Kingdom and said she intends to make a case for building the 787’s engines here.


From Paris, the mission will go to Mainz, Germany, seeking business from biotech and industrial machinery companies. The final stop is London.


In each city, the governor will also promote tourism in Washington, a popular destination for travelers from all three countries.


Seafoods industry



Magazine ranks Trident as tops



Trident Seafoods of Seattle is the industry’s biggest fish after increasing its revenue 23 percent to $800 million last year, according to SeaFood Business magazine.


Trident jumped from third place to first, due in part to last year’s acquisition of Norquest Seafoods, which contributed $100 million in sales. The company operates 34 vessels and 17 processing plants in Alaska, Washington and Oregon.


The trade publication’s latest issue ranks seven other local companies among the top 25 U.S. seafood producers.


Nippon Suisan USA of Redmond was seventh with $589 million in annual revenue, followed by Ocean Beauty Seafoods ($500 million) and American Seafoods Group ($462 million), both of Seattle.


Also on the list are Seattle-based Aqua Star, Icicle Seafoods, Peter Pan Seafoods and North Pacific Seafoods.


Frazier Healthcare



$475 million raised in venture capital



Seattle-based Frazier Healthcare said yesterday that it completed raising its fifth venture-capital fund totaling $475 million, making it one of the largest funds to be raised in the region.


Frazier Healthcare Ventures, which invests primarily on the West Coast, said it plans to put the money to work in various healthcare sectors, including biopharma and medical devices, and into companies in early-stage or late-stage development


The fund recently made its first investment in Santa Clara, Calif.-based FoviOptics. The medical-device company is developing a glucose monitor that reads blood-sugar levels by shining a light into a patient’s eye.


Along with Frazier Technology Ventures, the total money the firm has under management will be more than $1.3 billion.


Compiled from Seattle Times business staff